about
Causes and risk factors for anaphylaxisOmalizumab, an anti-immunoglobulin E antibody: state of the art.Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposalSurvey on practice of venom immunotherapy in FranceClinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria.Immunology of Bee Venom.Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement.
P2860
Q27009246-26DB9B5C-0647-40CF-9A9A-6051B4B25F1DQ35095218-86577177-C874-4170-9E66-E202C18C3D5EQ35574171-806A52FC-C7B3-45C9-A768-30537E66C0D0Q36582391-7105541A-8F13-4FF8-869D-DFFBE7DD07DFQ37876117-8533FD9C-EB2B-4A90-80C6-ADD67F76882FQ39096069-6746291B-3247-4B2D-8045-935BC60C18CBQ51533907-79AAC1CC-5343-4D6C-91C8-468BF162555E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stinging Hymenoptera and mastocytosis.
@en
Stinging Hymenoptera and mastocytosis.
@nl
type
label
Stinging Hymenoptera and mastocytosis.
@en
Stinging Hymenoptera and mastocytosis.
@nl
prefLabel
Stinging Hymenoptera and mastocytosis.
@en
Stinging Hymenoptera and mastocytosis.
@nl
P1476
Stinging Hymenoptera and mastocytosis.
@en
P2093
Bernhard Przybilla
Susanne Dugas-Breit
P304
P356
10.1097/ACI.0B013E32832D2BC7
P577
2009-08-01T00:00:00Z